Industry: Medical Devices & Consumables
Published Date: 2024-08-23
Pages: 85 Pages
Report ld: 3293786
Request Sample
Customized Report
Polysaccharide Hemostatic System (PHS) is a medical device for hemostasis consisting of absorbable modified polymer (AMP) particles and a drug delivery device. It is usually used in surgery or trauma care. It uses polysaccharides (such as gelatin, alginate, etc.) as the main component, which can quickly form gels and promote blood coagulation, thereby effectively controlling bleeding.
The global market for Polysaccharide Hemostatic System (PHS) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for Polysaccharide Hemostatic System (PHS) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Polysaccharide Hemostatic System (PHS) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Polysaccharide Hemostatic System (PHS) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Polysaccharide Hemostatic System (PHS) include OLYMPUS, CryoLife, Baxter, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Polysaccharide Hemostatic System (PHS), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polysaccharide Hemostatic System (PHS) by region & country, by Type, and by Application.
The Polysaccharide Hemostatic System (PHS) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polysaccharide Hemostatic System (PHS).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polysaccharide Hemostatic System (PHS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polysaccharide Hemostatic System (PHS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polysaccharide Hemostatic System (PHS) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Polysaccharide Hemostatic System (PHS) Product Introduction
1.2 Global Polysaccharide Hemostatic System (PHS) Market Size Forecast
1.2.1 Global Polysaccharide Hemostatic System (PHS) Sales Value (2019-2030)
1.2.2 Global Polysaccharide Hemostatic System (PHS) Sales Volume (2019-2030)
1.2.3 Global Polysaccharide Hemostatic System (PHS) Sales Price (2019-2030)
1.3 Polysaccharide Hemostatic System (PHS) Market Trends & Drivers
1.3.1 Polysaccharide Hemostatic System (PHS) Industry Trends
1.3.2 Polysaccharide Hemostatic System (PHS) Market Drivers & Opportunity
1.3.3 Polysaccharide Hemostatic System (PHS) Market Challenges
1.3.4 Polysaccharide Hemostatic System (PHS) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polysaccharide Hemostatic System (PHS) Players Revenue Ranking (2023)
2.2 Global Polysaccharide Hemostatic System (PHS) Revenue by Company (2019-2024)
2.3 Global Polysaccharide Hemostatic System (PHS) Players Sales Volume Ranking (2023)
2.4 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Company Players (2019-2024)
2.5 Global Polysaccharide Hemostatic System (PHS) Average Price by Company (2019-2024)
2.6 Key Manufacturers Polysaccharide Hemostatic System (PHS) Manufacturing Base and Headquarters
2.7 Key Manufacturers Polysaccharide Hemostatic System (PHS) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Polysaccharide Hemostatic System (PHS)
2.9 Polysaccharide Hemostatic System (PHS) Market Competitive Analysis
2.9.1 Polysaccharide Hemostatic System (PHS) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Polysaccharide Hemostatic System (PHS) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic System (PHS) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Automatic
3.1.2 Semi-automatic
3.2 Global Polysaccharide Hemostatic System (PHS) Sales Value by Type
3.2.1 Global Polysaccharide Hemostatic System (PHS) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Polysaccharide Hemostatic System (PHS) Sales Value, by Type (2019-2030)
3.2.3 Global Polysaccharide Hemostatic System (PHS) Sales Value, by Type (%) (2019-2030)
3.3 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Type
3.3.1 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Polysaccharide Hemostatic System (PHS) Sales Volume, by Type (2019-2030)
3.3.3 Global Polysaccharide Hemostatic System (PHS) Sales Volume, by Type (%) (2019-2030)
3.4 Global Polysaccharide Hemostatic System (PHS) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Polysaccharide Hemostatic System (PHS) Sales Value by Application
4.2.1 Global Polysaccharide Hemostatic System (PHS) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Polysaccharide Hemostatic System (PHS) Sales Value, by Application (2019-2030)
4.2.3 Global Polysaccharide Hemostatic System (PHS) Sales Value, by Application (%) (2019-2030)
4.3 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Application
4.3.1 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Polysaccharide Hemostatic System (PHS) Sales Volume, by Application (2019-2030)
4.3.3 Global Polysaccharide Hemostatic System (PHS) Sales Volume, by Application (%) (2019-2030)
4.4 Global Polysaccharide Hemostatic System (PHS) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Polysaccharide Hemostatic System (PHS) Sales Value by Region
5.1.1 Global Polysaccharide Hemostatic System (PHS) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Polysaccharide Hemostatic System (PHS) Sales Value by Region (2019-2024)
5.1.3 Global Polysaccharide Hemostatic System (PHS) Sales Value by Region (2025-2030)
5.1.4 Global Polysaccharide Hemostatic System (PHS) Sales Value by Region (%), (2019-2030)
5.2 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Region
5.2.1 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Region (2019-2024)
5.2.3 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Region (2025-2030)
5.2.4 Global Polysaccharide Hemostatic System (PHS) Sales Volume by Region (%), (2019-2030)
5.3 Global Polysaccharide Hemostatic System (PHS) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
5.4.2 North America Polysaccharide Hemostatic System (PHS) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
5.5.2 Europe Polysaccharide Hemostatic System (PHS) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
5.6.2 Asia Pacific Polysaccharide Hemostatic System (PHS) Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
5.7.2 South America Polysaccharide Hemostatic System (PHS) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
5.8.2 Middle East & Africa Polysaccharide Hemostatic System (PHS) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polysaccharide Hemostatic System (PHS) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Polysaccharide Hemostatic System (PHS) Sales Value
6.2.1 Key Countries/Regions Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Polysaccharide Hemostatic System (PHS) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.3.2 United States Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.4.2 Europe Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.5.2 China Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.6.2 Japan Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.7.2 South Korea Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.8.2 Southeast Asia Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Polysaccharide Hemostatic System (PHS) Sales Value, 2019-2030
6.9.2 India Polysaccharide Hemostatic System (PHS) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Polysaccharide Hemostatic System (PHS) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 OLYMPUS
7.1.1 OLYMPUS Company Information
7.1.2 OLYMPUS Introduction and Business Overview
7.1.3 OLYMPUS Polysaccharide Hemostatic System (PHS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 OLYMPUS Polysaccharide Hemostatic System (PHS) Product Offerings
7.1.5 OLYMPUS Recent Development
7.2 CryoLife
7.2.1 CryoLife Company Information
7.2.2 CryoLife Introduction and Business Overview
7.2.3 CryoLife Polysaccharide Hemostatic System (PHS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CryoLife Polysaccharide Hemostatic System (PHS) Product Offerings
7.2.5 CryoLife Recent Development
7.3 Baxter
7.3.1 Baxter Company Information
7.3.2 Baxter Introduction and Business Overview
7.3.3 Baxter Polysaccharide Hemostatic System (PHS) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Baxter Polysaccharide Hemostatic System (PHS) Product Offerings
7.3.5 Baxter Recent Development
8 Industry Chain Analysis
8.1 Polysaccharide Hemostatic System (PHS) Industrial Chain
8.2 Polysaccharide Hemostatic System (PHS) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polysaccharide Hemostatic System (PHS) Sales Model
8.5.2 Sales Channel
8.5.3 Polysaccharide Hemostatic System (PHS) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Polysaccharide Hemostatic System (PHS) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 117
USD 4900.00
(Single User License)
The global Polysaccharide Hemostatic System (PHS) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 70
USD 4250.00
(Single User License)
The global market for Polysaccharide Hemostatic System (PHS) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 85
USD 3950.00
(Single User License)
The global Polysaccharide Hemostatic System (PHS) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 94
USD 2900.00
(Single User License)
The global Polysaccharide Hemostatic System (PHS) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 127
USD 4900.00
(Single User License)
The global Polysaccharide Hemostatic System (PHS) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 65
USD 4250.00
(Single User License)
The global market for Polysaccharide Hemostatic System (PHS) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 82
USD 3950.00
(Single User License)
The global market for Polysaccharide Hemostatic System (PHS) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 76
USD 2900.00
(Single User License)
Polysaccharide Hemostatic System (PHS) is a medical device for hemostasis consisting of absorbable modified polymer (AMP) particles and a drug delivery device. It is usually used in surgery or trauma care. It uses polysaccharides (such as gelatin, alginate, etc.) as the main component, which can quickly form gels and promote blood coagulation, thereby effectively controlling bleeding.
Published Date: 2024-08-23
Pages: 81
USD 4350.00
(Single User License)
Polysaccharide Hemostatic System (PHS) is a medical device for hemostasis consisting of absorbable modified polymer (AMP) particles and a drug delivery device. It is usually used in surgery or trauma care. It uses polysaccharides (such as gelatin, alginate, etc.) as the main component, which can quickly form gels and promote blood coagulation, thereby effectively controlling bleeding.
Published Date: 2024-08-23
Pages: 69
USD 2900.00
(Single User License)
The global Polysaccharide Hemostatic System (PHS) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 117
The global Polysaccharide Hemostatic System (PHS) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 70
The global market for Polysaccharide Hemostatic System (PHS) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 85
The global Polysaccharide Hemostatic System (PHS) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 94
The global Polysaccharide Hemostatic System (PHS) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 127
The global Polysaccharide Hemostatic System (PHS) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 65
The global market for Polysaccharide Hemostatic System (PHS) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 82
The global market for Polysaccharide Hemostatic System (PHS) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 76
Polysaccharide Hemostatic System (PHS) is a medical device for hemostasis consisting of absorbable modified polymer (AMP) particles and a drug delivery device. It is usually used in surgery or trauma care. It uses polysaccharides (such as gelatin, alginate, etc.) as the main component, which can quickly form gels and promote blood coagulation, thereby effectively controlling bleeding.
Published: 2024-08-23
Pages: 81
Polysaccharide Hemostatic System (PHS) is a medical device for hemostasis consisting of absorbable modified polymer (AMP) particles and a drug delivery device. It is usually used in surgery or trauma care. It uses polysaccharides (such as gelatin, alginate, etc.) as the main component, which can quickly form gels and promote blood coagulation, thereby effectively controlling bleeding.
Published: 2024-08-23
Pages: 69
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now